SEC Info℠  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Promentis Pharmaceuticals, Inc. – ‘D’ on 12/27/19

On:  Friday, 12/27/19, at 1:33pm ET   ·   Effective:  12/27/19   ·   Accession #:  1470994-19-1   ·   File #:  21-356545

Previous ‘D’:  ‘D’ on 9/25/17   ·   Latest ‘D’:  This Filing

Find Words in Filings emoji
 		  in    Show  and   ↓Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

12/27/19  Promentis Pharmaceuticals, Inc.   D          12/27/19    1:9K

Notice of an Exempt Offering of Securities   —   Form D   —   Reg. D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: D           Notice of an Exempt Offering of Securities --       HTML      9K 
                primary_doc.xml/7.8


        

This ‘D’ Document is an XML Data File that may be rendered in various formats:

  Form D    –   Plain Text   –  SEC Website  –  EDGAR System  –    XML Data    –  <?xml?> File
 
 
XML Data rendering:  Notice of an Exempt Offering of Securities
 
                                                                                                                                                                                
<?xml version="1.0" encoding="windows-1252"?>
<edgarSubmission>
<schemaVersion> X0708 </schemaVersion>
<submissionType> D </submissionType>
<testOrLive> LIVE </testOrLive>
<primaryIssuer>
<cik> 0001470994 </cik>
<entityName> Promentis Pharmaceuticals, Inc. </entityName>
<issuerAddress>
<street1> 826 N. PLANKINTON AVE., STE. 400 </street1>
<city> MILWAUKEE </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</issuerAddress>
<issuerPhoneNumber> 414-238-2992 </issuerPhoneNumber>
<jurisdictionOfInc> DELAWARE </jurisdictionOfInc>
<issuerPreviousNameList>
<value> None </value>
</issuerPreviousNameList>
<edgarPreviousNameList>
<value> None </value>
</edgarPreviousNameList>
<entityType> Corporation </entityType>
<yearOfInc>
<overFiveYears> true </overFiveYears>
</yearOfInc>
</primaryIssuer>
<relatedPersonsList>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Daniel </firstName>
<lastName> Lawton </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Klaus </firstName>
<lastName> Veitinger </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Stacey </firstName>
<lastName> Seltzer </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Patrick </firstName>
<lastName> Schwarz-Schuette </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Thomas </firstName>
<lastName> Beck </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Steve </firstName>
<lastName> Squinto </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Director </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
<relatedPersonInfo>
<relatedPersonName>
<firstName> Chad </firstName>
<lastName> Beyer </lastName>
</relatedPersonName>
<relatedPersonAddress>
<street1> 826 North Plankinton Ave. </street1>
<street2> Ste. 400 </street2>
<city> Milwaukee </city>
<stateOrCountry> WI </stateOrCountry>
<stateOrCountryDescription> WISCONSIN </stateOrCountryDescription>
<zipCode> 53203 </zipCode>
</relatedPersonAddress>
<relatedPersonRelationshipList>
<relationship> Executive Officer </relationship>
</relatedPersonRelationshipList>
<relationshipClarification></relationshipClarification>
</relatedPersonInfo>
</relatedPersonsList>
<offeringData>
<industryGroup>
<industryGroupType> Pharmaceuticals </industryGroupType>
</industryGroup>
<issuerSize>
<revenueRange> Decline to Disclose </revenueRange>
</issuerSize>
<federalExemptionsExclusions>
<item> 06b </item>
</federalExemptionsExclusions>
<typeOfFiling>
<newOrAmendment>
<isAmendment> false </isAmendment>
</newOrAmendment>
<dateOfFirstSale>
<value> 2019-12-10 </value>
</dateOfFirstSale>
</typeOfFiling>
<durationOfOffering>
<moreThanOneYear> false </moreThanOneYear>
</durationOfOffering>
<typesOfSecuritiesOffered>
<isDebtType> true </isDebtType>
<isOptionToAcquireType> true </isOptionToAcquireType>
</typesOfSecuritiesOffered>
<businessCombinationTransaction>
<isBusinessCombinationTransaction> false </isBusinessCombinationTransaction>
<clarificationOfResponse></clarificationOfResponse>
</businessCombinationTransaction>
<minimumInvestmentAccepted> 0 </minimumInvestmentAccepted>
<salesCompensationList></salesCompensationList>
<offeringSalesAmounts>
<totalOfferingAmount> 6000000 </totalOfferingAmount>
<totalAmountSold> 2500000 </totalAmountSold>
<totalRemaining> 3500000 </totalRemaining>
<clarificationOfResponse></clarificationOfResponse>
</offeringSalesAmounts>
<investors>
<hasNonAccreditedInvestors> false </hasNonAccreditedInvestors>
<totalNumberAlreadyInvested> 8 </totalNumberAlreadyInvested>
</investors>
<salesCommissionsFindersFees>
<salesCommissions>
<dollarAmount> 0 </dollarAmount>
</salesCommissions>
<findersFees>
<dollarAmount> 0 </dollarAmount>
</findersFees>
<clarificationOfResponse></clarificationOfResponse>
</salesCommissionsFindersFees>
<useOfProceeds>
<grossProceedsUsed>
<dollarAmount> 0 </dollarAmount>
<isEstimate> true </isEstimate>
</grossProceedsUsed>
<clarificationOfResponse> Proceeds are used for research and development and general corporate purposes. The executive officers and certain directors will receive compensation from the Issuer's investment proceeds. </clarificationOfResponse>
</useOfProceeds>
<signatureBlock>
<authorizedRepresentative> false </authorizedRepresentative>
<signature>
<issuerName> Promentis Pharmaceuticals, Inc. </issuerName>
<signatureName> Daniel Lawton </signatureName>
<nameOfSigner> Daniel Lawton </nameOfSigner>
<signatureTitle> President </signatureTitle>
<signatureDate> 2019-12-23 </signatureDate>
</signature>
</signatureBlock>
</offeringData>
</edgarSubmission>


↑Top
Filing Submission 0001470994-19-000001   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help — Thu., May 16, 8:50:28.2pm ET